These results correlate with earlier findings by Kleffel et al. [130] that in aggressive melanoma populations, high expression of PD-1 and activation of the mTOR signaling pathway contributed to tumor progression, while inhibition of PD-1 signaling attenuated melanoma aggressiveness and metastasis. Here, MTOR is linked to melanoma.